Finance

Lists
RUBICON:NSE
Rubicon Research Ltd
1 530,00 INR
+0,43%
(+6,60) 1D
14-окт., 13:27:53 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RUBICON...
Open
1 513,90 INR
High
1 533,00 INR
Low
1 483,40 INR
Mkt. cap
253,26 млд
Avg. vol.
237,50 миң
Volume
71,82 миң
Dividend
0,10%
Quarterly dividend
0,38 INR
Ex-dividend date
2026-ж., 7-авг.
P/E ratio
87,66
52-wk high
1 899,00 INR
52-wk low
570,75 INR
EPS
17,45 INR
No. of employees
1 миң
Open
1 513,90 INR
High
1 533,00 INR
Low
1 483,40 INR
Mkt. cap
253,26 млд
Avg. vol.
237,50 миң
Volume
71,82 миң
Dividend
0,10%
Quarterly dividend
0,38 INR
Ex-dividend date
2026-ж., 7-авг.
P/E ratio
87,66
52-wk high
1 899,00 INR
52-wk low
570,75 INR
EPS
17,45 INR
No. of employees
1 миң
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
21 саат мурун
3 Indian Growth Stocks With ROE Above 22%
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai. The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1,29 миң
Founded1999
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 14-авг.
Fiscal period
Q1 2027
5,08 INR / 4,40 INR
+15,45%beat
Revenue / Est. (INR)
5,34 млд / 5,13 млд
+4,20%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
4,12 млд
4,76 млд
5,14 млд
5,34 млд
Cost of goods sold
1,27 млд
1,57 млд
1,86 млд
1,69 млд
Cost of revenue
1,27 млд
1,57 млд
1,86 млд
1,69 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633,59 млн
663,73 млн
699,04 млн
856,66 млн
Operating expense
2,03 млд
2,22 млд
2,21 млд
2,51 млд
Total operating expenses
3,30 млд
3,79 млд
4,07 млд
4,20 млд
Operating income
824,26 млн
965,73 млн
1,06 млд
1,14 млд
Other non operating income
6,97 млн
37,87 млн
-157,07 млн
56,83 млн
EBT including unusual items
717,05 млн
905,86 млн
986,87 млн
1,10 млд
EBT excluding unusual items
717,05 млн
905,86 млн
996,82 млн
1,10 млд
Income tax expense
178,53 млн
177,89 млн
219,02 млн
255,91 млн
Effective tax rate
24,90%
19,64%
22,19%
23,19%
Other operating expenses
1,28 млд
1,44 млд
1,39 млд
1,51 млд
Net income
538,52 млн
727,97 млн
767,85 млн
847,81 млн
Net profit margin
13,07%
15,31%
14,94%
15,87%
Earnings per share
3,47
4,41
4,60
5,08
Interest and investment income
-
-
79,68 млн
-
Interest expense
-114,18 млн
-97,74 млн
-
-92,88 млн
Net interest expenses
-114,18 млн
-97,74 млн
79,68 млн
-92,88 млн
Depreciation and amortization charges
118,71 млн
115,53 млн
122,66 млн
151,39 млн
EBITDA
976,82 млн
1,12 млд
1,14 млд
1,21 млд
Gain or loss from assets sale
7,63 млн
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору